Loading...
Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy in patients with metastatic breast cancer
Coe, Faye Misra, Vivek McCabe, Yamini Adderley, Helen Woodhouse, Laura Ayub, Zaheen Wang, Xin Howell, Sacha J Ekholm, Maria
Coe, Faye
Misra, Vivek
McCabe, Yamini
Adderley, Helen
Woodhouse, Laura
Ayub, Zaheen
Wang, Xin
Howell, Sacha J
Ekholm, Maria
Citations
Altmetric:
Abstract
Description
Date
2021
Publisher
Collections
Files
Loading...
From UNPAYWALL
Adobe PDF, 379.54 KB
Keywords
Type
Article
Citation
Coe F, Misra V, McCabe Y, Adderley H, Woodhouse L, Ayub Z, et al. Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy in patients with metastatic breast cancer Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021.